Showing 1 to 12 of 93 results
Most Seniors Cannot Avoid Medicare Part B Premiums, But Options Exist for Delay or Assistance
While most seniors cannot avoid Medicare Part B premiums, delaying enrollment is possible with creditable employer insurance, and financial assistance programs exist for low-income individuals.
Most Seniors Cannot Avoid Medicare Part B Premiums, But Options Exist for Delay or Assistance
While most seniors cannot avoid Medicare Part B premiums, delaying enrollment is possible with creditable employer insurance, and financial assistance programs exist for low-income individuals.
Progress
16% Bias Score
Medicare Reimbursement Cuts Reduce Physician Payments by 33.6%
A new report reveals a 33.6% decrease in physician Medicare payments over the past decade due to reimbursement cuts and rising practice costs, impacting access to care for seniors, especially those enrolled in Medicare Advantage plans.
Medicare Reimbursement Cuts Reduce Physician Payments by 33.6%
A new report reveals a 33.6% decrease in physician Medicare payments over the past decade due to reimbursement cuts and rising practice costs, impacting access to care for seniors, especially those enrolled in Medicare Advantage plans.
Progress
40% Bias Score
Long-Term Care Costs and Funding: A Critical Gap Between Public Perception and Reality
Two studies reveal that while many Americans anticipate needing long-term care, they underestimate its cost and misjudge funding sources; this has created a substantial financial risk for retirement, especially among middle-income individuals, and suggests a need for public policy solutions.
Long-Term Care Costs and Funding: A Critical Gap Between Public Perception and Reality
Two studies reveal that while many Americans anticipate needing long-term care, they underestimate its cost and misjudge funding sources; this has created a substantial financial risk for retirement, especially among middle-income individuals, and suggests a need for public policy solutions.
Progress
60% Bias Score
Medicare Funding for Gender-Affirming Surgeries Delayed Pending Further Research
Australia's Medical Services Advisory Committee (MSAC) delayed a Medicare funding application for 30 gender-affirming surgeries due to insufficient long-term outcome data, despite acknowledging unmet clinical needs and receiving over 2700 mostly supportive submissions; the committee requested furthe...
Medicare Funding for Gender-Affirming Surgeries Delayed Pending Further Research
Australia's Medical Services Advisory Committee (MSAC) delayed a Medicare funding application for 30 gender-affirming surgeries due to insufficient long-term outcome data, despite acknowledging unmet clinical needs and receiving over 2700 mostly supportive submissions; the committee requested furthe...
Progress
36% Bias Score
IRA's Impact: Lower Drug Costs for Medicare Cancer Patients
The Inflation Reduction Act capped annual out-of-pocket costs for Medicare Part D prescription drugs at $3,300 in 2024 and $2,000 in 2025, resulting in a 50% year-over-year increase in oncology prescription volumes between 2023 and 2024, significantly benefiting cancer patients.
IRA's Impact: Lower Drug Costs for Medicare Cancer Patients
The Inflation Reduction Act capped annual out-of-pocket costs for Medicare Part D prescription drugs at $3,300 in 2024 and $2,000 in 2025, resulting in a 50% year-over-year increase in oncology prescription volumes between 2023 and 2024, significantly benefiting cancer patients.
Progress
40% Bias Score
Medicare Advantage Plan Confusion Leads to Unexpected Medical Costs
A 2023 survey revealed that over 65% of participants found Medicare confusing; two friends experienced unexpectedly high medical costs after switching to an out-of-network Medicare Advantage HMO plan, highlighting the need for improved plan understanding and transparency.
Medicare Advantage Plan Confusion Leads to Unexpected Medical Costs
A 2023 survey revealed that over 65% of participants found Medicare confusing; two friends experienced unexpectedly high medical costs after switching to an out-of-network Medicare Advantage HMO plan, highlighting the need for improved plan understanding and transparency.
Progress
44% Bias Score
Medicare Delays Coverage for Updated Covid-19 Shots, Forcing Some Seniors to Pay Out-of-Pocket
Despite FDA approval, some Medicare beneficiaries aged 65 and older are being denied coverage for updated Covid-19 shots at pharmacies like CVS, leading to out-of-pocket costs of $225 or more, while others report delays due to system updates.
Medicare Delays Coverage for Updated Covid-19 Shots, Forcing Some Seniors to Pay Out-of-Pocket
Despite FDA approval, some Medicare beneficiaries aged 65 and older are being denied coverage for updated Covid-19 shots at pharmacies like CVS, leading to out-of-pocket costs of $225 or more, while others report delays due to system updates.
Progress
24% Bias Score
NDIS Reform: Potential Cost Increase for Families as Children Transition to Medicare
The Australian government will shift children with mild to moderate developmental delays and autism from the NDIS to the Thriving Kids scheme by mid-2027, potentially increasing families' medical costs due to limited Medicare rebates for therapies, despite assurances no child will be left without su...
NDIS Reform: Potential Cost Increase for Families as Children Transition to Medicare
The Australian government will shift children with mild to moderate developmental delays and autism from the NDIS to the Thriving Kids scheme by mid-2027, potentially increasing families' medical costs due to limited Medicare rebates for therapies, despite assurances no child will be left without su...
Progress
52% Bias Score
Medicare Part D Premiums Set to Surge Up to $50 Monthly
Medicare Part D enrollees face potential monthly premium increases up to \$50 in 2024 due to rising drug costs, the Inflation Reduction Act's cost shift to insurers, and reduced government funding for premium stabilization, prompting experts to urge beneficiaries to compare plans during open enrollm...
Medicare Part D Premiums Set to Surge Up to $50 Monthly
Medicare Part D enrollees face potential monthly premium increases up to \$50 in 2024 due to rising drug costs, the Inflation Reduction Act's cost shift to insurers, and reduced government funding for premium stabilization, prompting experts to urge beneficiaries to compare plans during open enrollm...
Progress
40% Bias Score
Low Enrollment in Medicare's New Prescription Payment Plan
The Inflation Reduction Act's $2,000 cap on Part D out-of-pocket drug costs in 2025 introduced the voluntary Medicare Prescription Payment Plan (MPPP), allowing enrollees to spread payments monthly; however, only 16% of the 1.2 million eligible beneficiaries enrolled by February 2025.
Low Enrollment in Medicare's New Prescription Payment Plan
The Inflation Reduction Act's $2,000 cap on Part D out-of-pocket drug costs in 2025 introduced the voluntary Medicare Prescription Payment Plan (MPPP), allowing enrollees to spread payments monthly; however, only 16% of the 1.2 million eligible beneficiaries enrolled by February 2025.
Progress
36% Bias Score
Bipartisan Bill Seeks to Address Physician Shortage with 14,000 New Residency Slots
A bipartisan bill aims to increase Medicare-funded residency positions by 14,000 over seven years to address a projected physician shortage of up to 86,000 by 2036, impacting patient care access nationwide.
Bipartisan Bill Seeks to Address Physician Shortage with 14,000 New Residency Slots
A bipartisan bill aims to increase Medicare-funded residency positions by 14,000 over seven years to address a projected physician shortage of up to 86,000 by 2036, impacting patient care access nationwide.
Progress
32% Bias Score
Medicare Tests Prior Authorization, Insurers Pledge Streamlining
Medicare is testing pre-approval for 17 services in six states starting January 1, 2026, aiming to reduce the $5.8 billion spent on unnecessary care in 2022, while over 50 major insurers will streamline prior authorization across plans by January 1, 2027.
Medicare Tests Prior Authorization, Insurers Pledge Streamlining
Medicare is testing pre-approval for 17 services in six states starting January 1, 2026, aiming to reduce the $5.8 billion spent on unnecessary care in 2022, while over 50 major insurers will streamline prior authorization across plans by January 1, 2027.
Progress
36% Bias Score
Showing 1 to 12 of 93 results